Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.0105 (5.83%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £2.52m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Interim Results

26 Sep 2006 16:46

Azure Holdings PLC26 September 2006 Azure Holdings Plc (" Company") Interim results for the six months ended 30 June 2006 Chairman's statement I am pleased to present the interim accounts for the six months ended 30 June2006. In the six months to 30 June 2006 the Company announced a loss after taxation of£138,000 (2005: £74,000). The figures should not reflect the future of the Company, which hopefully willmove forward successfully as ValiRx plc from early next month, because, asannounced on 11 September 2006, the reverse acquisition of ValiRx Limited hasbeen agreed and is subject to shareholders approval at the EGM scheduled for 2October 2006. If all the resolutions at that meeting are approved, the Company will retain itsAIM quotation and I will resign as Chairman leaving the new board and GerryDesler, Finance Director from the old board, to run the Company. Barry GoldChairman 26 September 2006 Azure Holdings plc Profit and Loss Account for the six months ended 30 June 2006 6 months ended 6 months ended Year ended 31 30 June 2006 30 June 2005 December 2005 (unaudited) (unaudited) (audited) £'000 £'000 £'000 Turnover - - - Administrative expenses (138) (74) (134) Operating loss (138) (74) (134) Loss on ordinary activities before taxation (138) (74) (134) Tax on loss on ordinary activities - - - Loss on ordinary activities after taxation (138) (74) (134) Retained loss for the period (138) (74) (134) Loss per ordinary share (0.12p) (0.15p) (0.28p) The profit and loss account has been prepared on the basis that all operationsare continuing operations. All recognised gains or losses are dealt withthrough the profit and loss account or statement of recognised gains and losses. Azure Holdings plc Balance Sheet as at 30 June 2006 30 June 2006 30 June 2005 31 December 2005 (unaudited) (unaudited) (audited) £'000 £'000 £'000Current assetsDebtors 9 3 1Cash at bank and in hand 127 1 1 136 4 2 Creditors: amounts falling due within one year (103) (147) (205) Net current assets/(liabilities) 33 (143) (203) Total assets less current liabilities 33 (143) (203) Net (liabilities)/assets 33 (143) (203) Capital and reservesCalled up Share Capital 6,271 5,475 5,475Share Premium 9,858 10,279 10,279Profit and loss account (16,096) (15,897) (15,957) Equity shareholders funds 33 (143) (203) Azure Holdings plc Cash Flow Statement for the six months ended 30 June 2006 6 months ended 6 months ended 30 June 2006 30 June 2005 (unaudited) (unaudited) £'000 £'000Net cash inflow (outflow) from operating activities (249) (13) FinancingIssue of ordinary shares 796 - Share premium reduction arising onconversion of loan stock (421) - Increase/(Decrease) in cash 126 (13) Azure Holdings plc Notes to the Interim Results 1. The interim results are unaudited and do not constitute statutoryaccounts within the meaning of section 240 of the Companies Act 1985. Thefigures for the year ended 31 December 2005 have been extracted from thestatutory accounts filed with the registrar of companies on which the auditorsgave an unqualified report. 2. The interim results have been prepared using the accountingpolicies set out in the statutory accounts for the year ended 31 December 2005. 3. The comparative figures for the unaudited interim results for theperiod ended 30 June 2005 are stated as announced on 27 September 2005. 4. Loss per share The loss per share for the six months ended 30 June 2006 has been calculated onthe basis of the loss after taxation for the period of £138,000 (2005: £74,000) and the weighted average number of shares in issue during the period of118,717,810 (2005: 48,317,569). . 5. The directors do not propose to pay a dividend for the period. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jan 20117:00 amRNSIssue of Equity
26th Jan 201110:58 amRNSResult of General Meeting
11th Jan 20117:00 amRNSPublication of Circular and Notice of GM
2nd Dec 20107:00 amRNSUpdate - Eurostars Programme
1st Dec 20107:00 amRNSTotal Voting Rights
10th Nov 20107:00 amRNSIssue of equity and update
1st Nov 20104:12 pmRNSTotal Voting Rights
29th Oct 20103:16 pmRNSIssue of Equity
29th Oct 20103:15 pmRNSChange of Adviser
11th Oct 201010:51 amRNSCompletion of Disposal
30th Sep 20102:17 pmRNSHalf Yearly Report
23rd Sep 20107:00 amRNSDisposal
31st Aug 20107:00 amRNSTotal Voting Rights
16th Aug 20105:12 pmRNSIssue of Equity
12th Aug 20107:00 amRNSLicensing Deal with Cancer Research Technology
15th Jul 20107:00 amRNSHPV Test Starts Clinical Validation
30th Jun 201010:15 amRNSResult of AGM
17th Jun 20107:00 amRNSEurostars' GeneICE Programme - First Year Review
17th Jun 20107:00 amRNSGeneICE Update
24th May 20107:00 amRNSRe Agreement
30th Apr 20102:47 pmRNSTotal Voting Rights
21st Apr 20104:08 pmRNSIssue of Equity - Replacement
21st Apr 20103:14 pmRNSResult of General Meeting
1st Apr 20103:19 pmRNSProposed reorg of share capital & Gen Meeting
1st Apr 201010:06 amRNSIssue of Equity
1st Apr 201010:06 amRNSTrading Update
31st Mar 20107:00 amRNSTotal Voting Rights
17th Mar 20107:00 amRNSSales and Distribution Agreement
15th Mar 201011:07 amRNSValiRx announces good stability data for VAL201
9th Mar 20107:00 amRNSFunding and Partnership Agreement
5th Mar 20103:00 pmRNSIssue of Equity
26th Feb 20104:30 pmRNSTotal Voting Rights
16th Feb 20109:00 amRNSIssue of Equity
29th Jan 201010:10 amRNSTotal Voting Rights
19th Jan 20107:00 amRNSGeneICE Update
13th Jan 20107:56 amRNSIssue of Equity
31st Dec 20098:03 amRNSIssue of Equity
30th Dec 20091:57 pmRNSResult of General Meeting
22nd Dec 200912:19 pmRNSRegional Funding
11th Dec 20097:42 amRNS?3m Equity Purchase Agreement
4th Dec 200910:14 amRNSNotice of General Meeting
25th Nov 20097:00 amRNSTrading Update
28th Sep 20097:40 amRNSHalf Yearly Report
14th Sep 20097:00 amRNSNew Distribution Venture & Trading Platform Launch
29th Jul 20098:06 amRNSAustralian Patent Acceptance
3rd Jul 200910:57 amRNSResult of AGM
10th Jun 20091:35 pmRNSFinal Results
10th Jun 20098:50 amRNSAward for cancer therapeutics project
29th May 20097:00 amRNSPlacing Summary and Total Voting Rights
11th May 20097:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.